Arkansas SB 140: TO MANDATE THE USE OF BIOSIMILAR MEDICINES UNDER HEALTH BENEFIT PLANS; TO REQUIRE A HEALTHCARE PROVIDER TO PRESCRIBE BIOSIMILAR MEDICINES; AND TO IMPROVE ACCESS TO BIOSIMILAR MEDICINES.

Status: Sine Die adjournment (as of 2025-05-05)

State: Arkansas · Session: 2025 · Bill: SB 140

Sponsors: Achor, J. Boyd

View Arkansas SB 140 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.